Breast Cancer: Targets and Therapy
Volume 11, 2019 - Issue
Open access
736
Views
38
CrossRef citations to date
0
Altmetric
Review
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
Nehad M Ayoub1 Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology (JUST), Irbid, Jordan, [email protected]Correspondence[email protected]
, Kamal M Al-Shami2 Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA
& Rami J Yaghan3 Department of General Surgery and Urology, Faculty of Medicine, Jordan University of Science and Technology (JUST), Irbid, Jordan
Pages 53-69
|
Published online: 17 Jan 2019
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.